In vitro anticancer activity evaluation of new cationic platinum(II) complexes based on imidazole moiety. 2017

Isabella Rimoldi, and Giorgio Facchetti, and Giorgio Lucchini, and Elisa Castiglioni, and Silvia Marchianò, and Nicola Ferri
Università degli Studi di Milano, Dipartimento di Scienze Farmaceutiche, Via Venezian 21, 20133 Milan, Italy. Electronic address: isabella.rimoldi@unimi.it.

The development and the synthesis of cationic platinum(II) complexes were realized and their cytotoxic activity was tested on triple negative breast cancer MDA-MB-231 cell line and in two cell lines poorly responsive to cisplatin (DLD-1 and MCF-7). The complex 2c resulted the most potent cytotoxic agent in MDA-MB-231 (IC50=61.9µM) and more effective than cisplatin on both DLD-1 (IC50=57.4µM) and MCF-7 (IC50=79.9µM) cell lines. 2c showed different cellular uptake and pharmacodynamic properties than cisplatin, interfering with the progression of the M phase of the cell cycle. Thus, 2c represents a lead compound of a new class of cytotoxic agents with promising antitumor activity.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D009944 Organoplatinum Compounds Organic compounds which contain platinum as an integral part of the molecule. Compounds, Organoplatinum
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D056148 Chromatography, Reverse-Phase A chromatography technique in which the stationary phase is composed of a non-polar substance with a polar mobile phase, in contrast to normal-phase chromatography in which the stationary phase is a polar substance with a non-polar mobile phase. Chromatography, Reversed-Phase Liquid,Reversed-Phase Chromatography,Reversed-Phase Liquid Chromatography,Reverse-Phase Chromatography,Reverse-Phase Liquid Chromatography,Chromatography, Reverse Phase,Chromatography, Reversed-Phase,Reverse Phase Chromatography,Reversed Phase Chromatography
D064726 Triple Negative Breast Neoplasms Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN. ER-Negative PR-Negative HER2-Negative Breast Cancer,ER-Negative PR-Negative HER2-Negative Breast Neoplasms,Triple Negative Breast Cancer,Triple-Negative Breast Cancer,Triple-Negative Breast Neoplasm,Breast Cancer, Triple-Negative,Breast Cancers, Triple-Negative,Breast Neoplasm, Triple-Negative,Breast Neoplasms, Triple-Negative,ER Negative PR Negative HER2 Negative Breast Cancer,ER Negative PR Negative HER2 Negative Breast Neoplasms,Triple Negative Breast Neoplasm,Triple-Negative Breast Cancers,Triple-Negative Breast Neoplasms

Related Publications

Isabella Rimoldi, and Giorgio Facchetti, and Giorgio Lucchini, and Elisa Castiglioni, and Silvia Marchianò, and Nicola Ferri
July 2021, Journal of biomolecular structure & dynamics,
Isabella Rimoldi, and Giorgio Facchetti, and Giorgio Lucchini, and Elisa Castiglioni, and Silvia Marchianò, and Nicola Ferri
November 2012, European journal of medicinal chemistry,
Isabella Rimoldi, and Giorgio Facchetti, and Giorgio Lucchini, and Elisa Castiglioni, and Silvia Marchianò, and Nicola Ferri
June 2020, ACS omega,
Isabella Rimoldi, and Giorgio Facchetti, and Giorgio Lucchini, and Elisa Castiglioni, and Silvia Marchianò, and Nicola Ferri
July 2021, International journal of molecular sciences,
Isabella Rimoldi, and Giorgio Facchetti, and Giorgio Lucchini, and Elisa Castiglioni, and Silvia Marchianò, and Nicola Ferri
August 2002, Toxicology in vitro : an international journal published in association with BIBRA,
Isabella Rimoldi, and Giorgio Facchetti, and Giorgio Lucchini, and Elisa Castiglioni, and Silvia Marchianò, and Nicola Ferri
November 2017, Nucleosides, nucleotides & nucleic acids,
Isabella Rimoldi, and Giorgio Facchetti, and Giorgio Lucchini, and Elisa Castiglioni, and Silvia Marchianò, and Nicola Ferri
August 2016, Journal of photochemistry and photobiology. B, Biology,
Isabella Rimoldi, and Giorgio Facchetti, and Giorgio Lucchini, and Elisa Castiglioni, and Silvia Marchianò, and Nicola Ferri
February 2018, Journal of inorganic biochemistry,
Isabella Rimoldi, and Giorgio Facchetti, and Giorgio Lucchini, and Elisa Castiglioni, and Silvia Marchianò, and Nicola Ferri
September 2018, Journal of biomolecular structure & dynamics,
Isabella Rimoldi, and Giorgio Facchetti, and Giorgio Lucchini, and Elisa Castiglioni, and Silvia Marchianò, and Nicola Ferri
January 1994, Archivum immunologiae et therapiae experimentalis,
Copied contents to your clipboard!